Here's a sad mess. It seems a potentially important finding -- that getting a seasonal flu shot might increase risk of contracting the swine flu -- is being sat on by a journal, with the authors forbidden from talking about it, until they get through the slo-mo publishing process.
The finding may or may not be accurate. But as it regards an important issue, it needs to be vetted and discussed openly, with the data at hand, as soon as possible. But it's not.
This is a tricky situation, to be sure. There are, at least theoretically, both good and bad reasons to withhold this information. But it seems to me the bad outweigh the good here, and both science and the public interest would benefit from a full airing of this study asap. At minimum, the journal holding the paper (which journal's id we don't even know) should state its reasons for doing so. I hope they're good ones.
The good argument for withholding this information is that the journal's peer reviewers need time to finish their review. Okay as far as it goes -- only in this case, I don't think it goes very far. For many subjects, three peer reviewers is about all you're going to muster to vet a paper. But in a case this urgent and high-profile, you'd get a much more thorough airing if you released the thing, for scores of epidemiologists -- whole armies of them, actually, all over the world -- would be eager to help out. Unless there's something we're missing here, it woulud seem much more helpful to let these findings get vetted out in the open, by the entire epidemiological community, by publishing the study and the underlying data online asap so that a little open science can be done. Let the hivemind at it.
Instead, we get rumors of an unsettling finding -- and a process that just flat looks bad.
And this gets us to the bad reasons for sitting on a paper like this: the proprietary embargo disguised as careful review. As a journalist, I run into this all the time. Findings -- non-peer-reviewed so far, yes, but still of interest and often based on substantial work, and very often already aired in public at conferences and meeting -- can't be discussed "on the record" because ... well, because the journal wants to be the one to break the story. Particularly upsetting is that the authors aren't allowed to talk to the press about their findings, having been forbidden to do so by the journals. This gag practice is not so much in the interest of ensuring accuracy as it is of ensuring a splash when the journal publishes the paper.
I find it hard to fault the scientists in these cases; they know well that if they break a journal's gag order, their chances of publishing again at that journal are quite slim. This is questionable enough in any case, and especially given that science is ultimately a collaborative endeavor. But when issues of public health are clearly and directly at stake, it's particularly hard to defend.
Here's the thread; see what you make of it yourself.
Here's the main news kernal, from the ever-alert ace flu reporter Helen Branswell:
The Canadian Press
Unpublished Canadian data are raising concerns about whether it's a good idea to get a seasonal flu shot this season.
Drawn from a series of studies from British Columbia, Quebec and Ontario, the data appear to suggest that people who got a seasonal flu shot last year are about twice as likely to catch swine flu as people who didn't.
A scientific paper has been submitted to a journal and the lead authors - Dr. Danuta Skowronski of the British Columbia Centre for Disease Control and Dr. Gaston De Serres of Laval University - won't speak to the media. Journals bar would-be authors from discussing their results publicly before they go through peer review.
While few people appear to have actually seen or read the study, the puzzling findings have been a poorly kept secret and many in the public health community in Canada have heard about them.
This shouldn't be something that flu experts feel compelled to discuss sotto voce. If the journal has good reasons to sit on the paper for now, it should declare them. If not, it should get the paper out in the open so the data and findings can be examined and vetted openly.
Update 9/25/09, 9:25 am EST: Two things:
- As per my comment below, I was glad to read this morning a thread at FluTrackers
that the CDC and Health Canada will be discussing this whole flap this
afternoon -- apparently at 1:30 pm EST by the CDC and 2:00pm EST by
Health Canada (though I can't find those at the CDC and Health Canda
sites!). Not clear whether they'll make the paper public or whether the journal will step up.
- Helen Branswell reports this morning that the (rumored/unconfirmed) small f findings have led Canadian officials to decide to delay seasonal flu shots for most people until after the H1N1 shots become available in November, so that the latter, being given earlier, can work without any possibility of, ah, influence from the former, now to be given later.
Comments
This was all over the news this morning, and I was hoping to get my hands on the actual paper before getting bombarded with questions. My office is a nightmare.
Gah. Thanks a whole freaking bunch, CBC.
Posted by: red rabbit | September 24, 2009 7:13 PM
This is the problem with for-profit journals putting their profits ahead of the public good. The journal better have a damn good reason for delaying publication or I suggest that scientists boycott the publisher and migrate to open access journals.
Posted by: daedalus2u | September 24, 2009 7:31 PM
I am not a doctor, so assuming this was true, could somone explain to me why would the seasonal flu vaccine increase the risk of getting swine flu?
Posted by: Alex | September 24, 2009 7:57 PM
*GUESSING*
This might have something to do with antigenic sin. So, say you got the seasonal flu vaccine last year. Maybe theres a little bit on it that your antibodies recognize-- when antibodies recognize this same little bit on a seasonal flu virus, the viruses are neutralized, and YAY, you dont get the flu!
Maybe swine flu has a bit on it that looks like the little bit on the seasonal flu vaccine, but antibodies to it are non-neutralizing. So your body is primed to make an antibody that doesnt work, and wont make antibodies that do work.
This is a potential problem with all flu vaccines... and just getting the flu... Seasonal or swine.
Posted by: ERV | September 24, 2009 8:00 PM
Couldn't such a correlation result from the right people (those at risk) having taken the vaccine last year?
At risk for flu in 2008 -> Take 2008 flu vaccine -> (Still) at risk for flu in 2009 -> Get flu (with the novel H1N1 strain now predominating) in 2009
Of course, I agree with the OP wholeheartedly that having access to the actual paper would be extremely helpful in sorting it out.
Posted by: Douglas McClean | September 24, 2009 9:28 PM
This sounds closer to poor science and not just journalistic profit hoarding. It could also be the case of a few scientists taking advantage of the swine flu hype to convert otherwise poor epidemiology into a paper. Maybe those people who received the flu vaccine were more likely to get tested for swine flu when they had flu like symptoms? Or maybe those individuals who wanted to get a vaccine were more likely to approach the medical establishment when they had flu like symptoms? Maybe it is just bad luck. If there are people in the know holding this till they can do a few serum assays or a little bit of tissue culture work that would be a great call. And you couldn't really announce that you were doing that without inadvertently giving a media sound-bite.
If the press release said the following I would be a lot more worried.
"Drawn from a series of studies from British Columbia, Quebec and Ontario, the data appear to suggest that people who got a seasonal flu shot last year have serum that cannot neutralize swine flu as effectively people who didn't."
or
"Drawn from a series of studies from British Columbia, Quebec and Ontario and controlling for a wide range of variables, the data appear to suggest that people who got a seasonal flu shot last year are about twice as likely to catch swine flu as people who didn't."
Either way this gets read even despite the writers abundant qualifiers as flu vaccine causes swine flu.
Posted by: Theodore | September 24, 2009 9:40 PM
The population that gets the seasonal flew vaccine is skewed towards vulnerable populations because public health policy and doctors push those people harder to get the vaccines. That population would obviously be more vulnerable to getting H1N1 too. This isn't my research area, but, if I were a reviewer of that manuscript, I'd definitely be trying to confirm that the authors addressed the skewed population issue in some manner.
I definitely think this should have been kept quieter until reviewers has a chance to comment and it was grossly irresponsible for the CBC to publicize this. If it turns out to be bad science, this will still be taking a life of it's own now. That all said, those reviewers should consider evaluating this article as their top priority and the journal should release the article immediately if it deems it quality science.
Posted by: bsci | September 24, 2009 10:15 PM
The article should have been sent to PLoS ONE to begin with.
Posted by: Greg Laden | September 24, 2009 10:49 PM
Or even faster, to PLoS Currents - Influenza.
Posted by: Coturnix | September 24, 2009 10:53 PM
Maybe people who get flu vaccines are then less fastidious about the hand-washing and staying away from people who are sick?
Posted by: Mark B | September 25, 2009 8:48 AM
Thanks to everyone for the extremely interesting comments. Many aspects, dimensions, crags, and crannies to this story. As some of you noted, it might be the science is just shoddy; then again, maybe not. And the findings may be just picking up selection biases of the sort mentioned by ERV or bsci above.
But light is needed at this point, and I was glad to read this morning a thread at FluTrackers that the CDC and Health Canada will be discussing this whole flap this afternoon -- apparently at 1:30 pm EST by the CDC and 2:00pm EST by Health Canada (though I can't find those at the CDC and Health Canda sites!).
Posted by: David Dobbs | September 25, 2009 8:58 AM
The CDC webcast is at flu.gov/live. He's in the Q&A; segment as I type this and hasn't addressed this issue at all yet.
Posted by: Rev Matt | September 25, 2009 2:29 PM
He did finally address "The Canada issue" twice, both times by saying "there's no published studies indicating any problem so la la la la la."
Posted by: Rev Matt | September 25, 2009 2:48 PM
I definitely think this should have been kept quieter until reviewers has a chance to comment and it was grossly irresponsible for the CBC to publicize this.
Posted by: acı cehre | September 25, 2009 8:56 PM
I definitely think this should have been kept quieter until reviewers has a chance to comment and it was grossly irresponsible for the CBC to publicize this.
Posted by: acı cehre | September 25, 2009 8:58 PM
This sounds closer to poor science and not just journalistic profit hoarding.
Posted by: vpills | September 25, 2009 9:00 PM
God, I hate science by press release. It's vile.
The study hasn't been published yet, and there is a way of vetting it. It's called peer review. Moreover, it's pretty standard practice at journals to tell authors not to discuss with the press a paper under peer review.
In any case, this sounds like a load of crap. Whenever you see this sort of story, it's always a good idea to be very, very skeptical of whether the science is any good or not. Usually it's not. It was hugely irresponsible of the CBC to publicize this before peer review had had it's chance to run its course.
Posted by: Orac | October 4, 2009 11:50 PM
Actually, I meant to say "science by press leak," not science by press release. Which is way, way worse than science by press release.
Posted by: Orac | October 4, 2009 11:51 PM
I'm not sure I'd fault the CBC here -- or think it's early to do so, at any rate. For one thing, to do so is to assume Helen Branswell is being successfully worked; possible, as we all have our off days, but unlikely.
The bigger problem in this case seems to be the closed system, in which research on a subject important to public health is bottled up and, far as anyone can tell, not discussed openly even among the immunology community.
That said, this is indeed complicated. As I noted before, there are good and bad reasons for holding onto this paper. The good is to have it evaluated quietly out of the spotlight. (Though as I've noted before, peer review is no guarantee this will happen.) That's no longer possible. If they haven't done so already, the journal editors should have this paper and its data being vetted by a wider community, including teams at CDC and Health Canada, or offer good reasons for not doing so. (Conceivably they've done so while I was tending the kids this weekend; if so ... good.)
Posted by: David Dobbs | October 5, 2009 6:55 AM